Home - Products - Angiogenesis - c-Met/HGFR - c-Met inhibitor 1

c-Met inhibitor 1

CAS No. 1357072-61-7

c-Met inhibitor 1( —— )

Catalog No. M22126 CAS No. 1357072-61-7

c-Met inhibitor 1 is a c-Met receptor signaling pathway inhibitor, used for the treatment of cancer including glioblastoma, gastric, and pancreatic cancer.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	69	In Stock
5MG	63	In Stock
10MG	93	In Stock
25MG	188	In Stock
50MG	276	In Stock
100MG	431	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

c-Met inhibitor 1
Note

Research use only, not for human use.
Brief Description

c-Met inhibitor 1 is a c-Met receptor signaling pathway inhibitor, used for the treatment of cancer including glioblastoma, gastric, and pancreatic cancer.
Description

c-Met inhibitor 1 is a c-Met receptor signaling pathway inhibitor, used for the treatment of cancer including glioblastoma, gastric, and pancreatic cancer.
In Vitro

——
In Vivo

——
Synonyms

——
Pathway

Angiogenesis
Target

c-Met/HGFR
Recptor

c-Met
Research Area

——
Indication

——

Chemical Information

CAS Number

1357072-61-7
Formula Weight

362.41
Molecular Formula

C17H14N8S
Purity

>98% (HPLC)
Solubility

DMSO:18 mg/mL (49.67 mM; Need ultrasonic)
SMILES

Cn1cc(cn1)-c1ccc2nnc(Sc3ccc4nn(C)cc4c3)n2n1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1. PCT Int. Appl. (2012), WO 2012015677 A1 20120202.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Altiratinib

Altiratinib(DCC-2701) is a novel c-MET/TIE-2/VEGFR inhibitor.
LMTK3-IN-1

Lmtk3-in-1 is a potent ATP-competitive lemur tyrosine kinase 3 (LMTK3) (Kd=2.5 μM) inhibitor that degrades LMTK3 through the ubiquitin proteasome pathway.
JUN04542

JUN04542 is an Axl Mer cMet KDR inhibitor for the treatment of Axl and Mer receptor tyrosine kinase- dependent disorders.

Sign In Join Free